Gastroenterology

Gastroenterology

Volume 148, Issue 1, January 2015, Pages 215-219
Gastroenterology

AGA Section
American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy

https://doi.org/10.1053/j.gastro.2014.10.039Get rights and content

Abbreviations used in this paper

AGA
American Gastroenterological Association
anti-HBc
antibody to hepatitis B core antigen
anti-HBs
antibody to hepatitis B surface antigen
CI
confidence interval
GRADE
Grading of Recommendations Assessment, Development and Evaluation
HBsAg
hepatitis B surface antigen
HBV
hepatitis B virus
HBVr
hepatitis B virus reactivation

Cited by (0)

Conflicts of interest All members were required to complete disclosure statements. These statements are maintained at the American Gastroenterological Association Institute headquarters in Bethesda, Maryland, and pertinent disclosures are published with the report.

Reprint requests Address requests for reprints to: Chair, Clinical Practice and Quality Management Committee, AGA National Office, 4930 Del Ray Avenue, Bethesda, Maryland 20814. e-mail: [email protected]; telephone: (301) 941-2618.

View Abstract